{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:06:00Z","timestamp":1767139560541,"version":"build-2238731810"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00380-024-02407-4","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T02:02:11Z","timestamp":1714442531000},"page":"845-856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between pre-treatment with statin and its inhibitory effect on the onset of coronary artery disease at the time of coronary computed tomography angiography: a new look at an old medication"],"prefix":"10.1007","volume":"39","author":[{"given":"Erika","family":"Miura-Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Kawahira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kuwano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Otsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichiro","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"2407_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.pharmthera.2010.01.008","volume":"126","author":"MJ Chapman","year":"2010","unstructured":"Chapman MJ, Redfern JS, McGovern ME, Giral P (2010) Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk. Pharmacol Ther 126:314\u2013345","journal-title":"Pharmacol Ther"},{"key":"2407_CR2","doi-asserted-by":"crossref","unstructured":"Sever PS, Dahl\u00f6f B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT investigators (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial\u2013Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 361:1149\u20131158","DOI":"10.1016\/S0140-6736(03)12948-0"},{"key":"2407_CR3","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195\u20132207","journal-title":"N Engl J Med"},{"key":"2407_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ahj.2021.06.009","volume":"240","author":"M Abe","year":"2021","unstructured":"Abe M, Ozaki Y, Takahashi H, Ishii M, Masunaga N, Ismail TF, Iimuro S, Fujita R, Iwata H, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Ogawa H, Daida H, Shimokawa H, Saito Y, Matsuzaki M, Akao M, Kimura T, Nagai R (2021) Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudy. Am Heart J 240:89\u2013100","journal-title":"Am Heart J"},{"key":"2407_CR5","doi-asserted-by":"crossref","unstructured":"Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, ASTEROID Investigators (2006) Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295:1556\u20131565","DOI":"10.1001\/jama.295.13.jpc60002"},{"key":"2407_CR6","doi-asserted-by":"crossref","unstructured":"Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN, REVERSAL Investigators (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291:1071\u20131080","DOI":"10.1001\/jama.291.9.1071"},{"key":"2407_CR7","doi-asserted-by":"crossref","unstructured":"Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, Yamaguchi T, Matsuzaki M, COSMOS Investigators (2009) Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J 73:2110\u20132117","DOI":"10.1253\/circj.CJ-09-0358"},{"key":"2407_CR8","doi-asserted-by":"crossref","unstructured":"Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M, JAPAN-ACS Investigators (2009) Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 54:293\u2013302","DOI":"10.1161\/circ.118.suppl_18.S_657-c"},{"key":"2407_CR9","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","volume":"368","author":"Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y, MEGA Study Group","year":"2006","unstructured":"Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y, MEGA Study Group (2006) Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 368:1155\u20131163","journal-title":"Lancet"},{"key":"2407_CR10","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group (1994) The Scandinavian Simvastatin Survival Study (4S) (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383\u20131389","journal-title":"Lancet"},{"key":"2407_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1253\/circj.70.1122","volume":"70","author":"R Mitsutake","year":"2006","unstructured":"Mitsutake R, Niimura H, Miura S, Zhang B, Iwata A, Nishikawa H, Kawamura A, Kumagai K, Shirai K, Matsunaga A, Saku K (2006) Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients. Circ J 70:1122\u20131127","journal-title":"Circ J"},{"key":"2407_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41440-020-00545-6","volume":"44","author":"Y Tsukihashi","year":"2021","unstructured":"Tsukihashi Y, Shiga Y, Suematsu Y, Idemoto Y, Tashiro K, Yano Y, Kato Y, Kuwano T, Sugihara M, Miura S (2021) Presence and severity of coronary artery disease in patients who achieved intensive blood pressure reduction at the time of coronary computed tomography angiography. Hypertens Res 44:206\u2013214","journal-title":"Hypertens Res"},{"key":"2407_CR13","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.3390\/jcm10112431","volume":"10","author":"H Inoue","year":"2021","unstructured":"Inoue H, Shiga Y, Norimatsu K, Tashiro K, Futami M, Suematsu Y, Sugihara M, Nishikawa H, Katsuda Y, Miura S (2021) Associations between high-density lipoprotein functionality and major adverse cardiovascular events in patients who have undergone coronary computed tomography angiography. J Clin Med 10:2431","journal-title":"J Clin Med"},{"key":"2407_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00380-021-01831-0","volume":"36","author":"Y Kawahira","year":"2021","unstructured":"Kawahira Y, Shiga Y, Inoue H, Suematsu Y, Tashiro K, Kato Y, Fujimi K, Takamiya Y, Kuwano T, Sugihara M, Miura S (2021) Association between high-density lipoprotein cholesterol levels and major adverse cardiovascular events in patients who underwent coronary computed tomography angiography: FU-CCTA registry. Heart Vessels 36:1457\u20131465","journal-title":"Heart Vessels"},{"key":"2407_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/cr1180","volume":"12","author":"H Inoue","year":"2021","unstructured":"Inoue H, Shiga Y, Tashiro K, Kawahira Y, Suematsu Y, Idemoto Y, Tano K, Kuwano T, Sugihara M, Nishikawa H, Katsuda Y, Miura S (2021) Association between the level of low-density lipoprotein cholesterol and coronary atherosclerosis in patients who have undergone coronary computed tomography angiography. Cardiol Res 12:10\u201315","journal-title":"Cardiol Res"},{"key":"2407_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.14740\/jocmr4367","volume":"12","author":"K Tashiro","year":"2020","unstructured":"Tashiro K, Inoue H, Shiga Y, Tsukihashi Y, Imaizumi T, Norimatsu K, Idemoto Y, Kuwano T, Sugihara M, Nishikawa H, Katsuda Y, Miura S (2020) Associations between high levels of high-density lipoprotein cholesterol and the presence and severity of corona artery disease in patients who have undergone coronary computed tomography angiography. J Clin Med Res 12:734\u2013739","journal-title":"J Clin Med Res"},{"key":"2407_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00380-016-0837-7","volume":"32","author":"K Norimatsu","year":"2017","unstructured":"Norimatsu K, Kuwano T, Miura S, Shimizu T, Shiga Y, Suematsu Y, Miyase Y, Adachi S, Nakamura A, Imaizumi S, Iwata A, Nishikawa H, Uehara Y, Saku K (2017) Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with orwithout coronary artery disease. Heart Vessels 32:30\u201338","journal-title":"Heart Vessels"},{"key":"2407_CR18","doi-asserted-by":"publisher","first-page":"870","DOI":"10.5551\/jat.3889","volume":"17","author":"Y Shiga","year":"2010","unstructured":"Shiga Y, Miura S, Mitsutake R, Kawamura A, Uehara Y, Saku K (2010) Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined byMDCT in patients with suspected coronary artery disease. J Atheroscler Thromb 17:870\u2013878","journal-title":"J Atheroscler Thromb"},{"key":"2407_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijcard.2009.01.058","volume":"143","author":"R Mitsutake","year":"2010","unstructured":"Mitsutake R, Miura S, Zhang B, Saku K (2010) HDL-associated factors provide additional prognostic information for coronary artery disease as determined by muldetector row computed tomography. Int J Cardiol 143:72\u201378","journal-title":"Int J Cardiol"},{"key":"2407_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827\u2013832","journal-title":"J Am Coll Cardiol"},{"key":"2407_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","volume":"51","author":"GG Gensini","year":"1983","unstructured":"Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606","journal-title":"Am J Cardiol"},{"key":"2407_CR22","doi-asserted-by":"crossref","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Bor\u00e9n J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybj\u00e6rg-Hansen A, European Atherosclerosis Society Consensus Panel (2013) Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 34:3478\u20133490. Erratum in: Eur Heart J 2020;41:4517","DOI":"10.1093\/eurheartj\/eht273"},{"key":"2407_CR23","unstructured":"NDB open data (2021) https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000177182.html accessed date 8th Nov. 2023"},{"key":"2407_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","volume":"92","author":"Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW, STELLAR Study Group","year":"2003","unstructured":"Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW, STELLAR Study Group (2003) Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol 92:152\u2013160","journal-title":"Am J Cardiol"},{"key":"2407_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJM200202143460721","volume":"346","author":"JA Staffa","year":"2002","unstructured":"Staffa JA, Chang J, Green L (2002) Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 346:539\u2013540","journal-title":"N Engl J Med"},{"key":"2407_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1194\/jlr.M011080","volume":"52","author":"AJ Tremblay","year":"2011","unstructured":"Tremblay AJ, Lamarche B, Lemelin V, Hoos L, Benjannet S, Seidah NG, Davis HR Jr, Couture P (2011) Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. J Lipid Res 52:558\u2013565","journal-title":"J Lipid Res"},{"key":"2407_CR27","doi-asserted-by":"crossref","unstructured":"Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR, FOURIER Steering Committee and Investigators (2017) Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 376:1713\u20131722","DOI":"10.1056\/NEJMoa1615664"},{"key":"2407_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/MOL.0000000000000896","volume":"34","author":"DG Karalis","year":"2023","unstructured":"Karalis DG (2023) Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease. Curr Opin Lipidol 34:252\u2013258","journal-title":"Curr Opin Lipidol"},{"key":"2407_CR29","doi-asserted-by":"publisher","DOI":"10.5551\/jat.GL2022","author":"T Okamura","year":"2003","unstructured":"Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H (2003) Japan atherosclerosis society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022. J Atheroscler Thromb. https:\/\/doi.org\/10.5551\/jat.GL2022","journal-title":"J Atheroscler Thromb"}],"updated-by":[{"DOI":"10.1007\/s00380-025-02536-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000}}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02407-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-024-02407-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02407-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T22:53:11Z","timestamp":1742424791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-024-02407-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2407"],"URL":"https:\/\/doi.org\/10.1007\/s00380-024-02407-4","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"6 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The  sentence \u201cPatients were classifed into two groups according to the presence or absence of pre-treatment with statin at the time of CCTA [statin (\u2212) group (n=826) and (+) group (n=364)].\u201d under the sub heading \u201cAssessment of patient backgrounds\u201d of \u201cSubjects and methods\u201d which was mistakenly included has been removed now","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00380-025-02536-4","URL":"https:\/\/doi.org\/10.1007\/s00380-025-02536-4","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}